Nula Therapeutics is pioneering a new class of medicines to treat metabolic dysfunction, neurodegeneration, and cancer by targeting the nuclear envelope of cells
Nula Therapeutics is pioneering a new class of medicines to treat metabolic dysfunction, neurodegeneration, and cancer by targeting the nuclear envelope of cells.